Clinical trial
A Single-Center, Open-Label Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark Spots
NCT07933380 is registered in ClinicalTrials.gov with Revision Skincare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Open-Label Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark Spots
- Lead sponsor
- Revision Skincare
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2026
- Completion date
- July 7, 2026
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pigmentation, post - inflammatory hyperpigmentation
Arms
As registered; 1 arm.
-
Brightening Serum and Brightening Pads
From baseline to week 12, subjects will apply a Brightening Serum (2x daily), and brightening pads 3 times per week in the evening only (Monday, Wednesday, Friday) or (Tuesday, Thursday, Saturday).
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Improvement of Clinical Efficacy Parameters at 2, 4, 8, and 12 weeks versus Baseline
A board-certified dermatologist will grade skin tone evenness, overall appearance, and PIH at baseline and at weeks 2, 4, 8, and 12. Skin tone evenness and overall appearance will be graded using the modified Griffiths 10-point scale (0 = Even healthy skin color; 9 = Uneven, discolored appearance), while PIH will be measured using a 4-point investigator global assessment scale (0 = clear, 1 = mild, 2 = moderate, and 3 = severe). Higher scores indicate greater severity of the respective skin condition, where a decrease in score indicates an improvement.
-
Measurement of subject self assessment questionnaire
Subjects will complete a self-assessment questionnaire which will consist of a series of questions related to subjects' evaluation of product efficacy and attributes. Subjects are asked to rate based on a scoring system of the following: from 5 (completely agree) to 1 (completely disagree). The best outcome is to Completely Agree with the statement / question being asked.
Lead sponsor's other trials
Revision Skincare, most recent start first.
+14 more trials See the organization page
Similar trials
Same condition (Hyperpigmentation) and phase, most recent start first.
+65 more trials See the condition page